T

Tri Chemical Laboratories Inc
TSE:4369

Watchlist Manager
Tri Chemical Laboratories Inc
TSE:4369
Watchlist
Price: 3 005 JPY Market Closed
Market Cap: 97.7B JPY
Have any thoughts about
Tri Chemical Laboratories Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Tri Chemical Laboratories Inc

Current Assets 19.7B
Cash & Short-Term Investments 9.5B
Receivables 5.3B
Other Current Assets 4.9B
Non-Current Assets 13.9B
Long-Term Investments 3.4B
PP&E 9.8B
Intangibles 85m
Other Non-Current Assets 561.7m
Current Liabilities 3.2B
Accounts Payable 577m
Accrued Liabilities 183.9m
Other Current Liabilities 2.5B
Non-Current Liabilities 1.5B
Long-Term Debt 1B
Other Non-Current Liabilities 486.6m

Balance Sheet
Tri Chemical Laboratories Inc

Rotate your device to view
Balance Sheet
Currency: JPY
Jan-2015 Jan-2016 Jan-2017 Jan-2018 Jan-2019 Jan-2020 Jan-2021 Jan-2022 Jan-2023 Jan-2024
Assets
Cash & Cash Equivalents
792
831
1 496
1 134
1 596
1 618
1 699
8 034
11 138
10 497
Cash Equivalents
792
831
1 496
1 134
1 596
1 618
1 699
8 034
11 138
10 497
Total Receivables
1 905
2 203
1 805
2 365
2 851
3 056
3 902
3 896
4 562
4 035
Accounts Receivables
1 706
2 016
1 678
2 239
2 851
3 056
3 902
3 896
4 562
4 035
Other Receivables
199
187
126
126
0
0
0
0
0
0
Inventory
574
631
667
836
933
1 226
1 609
2 150
2 740
4 023
Other Current Assets
83
92
74
151
58
247
375
305
483
453
Total Current Assets
3 357
3 757
4 041
4 486
5 437
6 147
7 585
14 386
18 923
19 009
PP&E Net
1 810
2 123
2 636
3 559
3 944
5 916
7 880
8 014
8 373
9 269
PP&E Gross
1 810
2 123
2 636
3 559
3 944
5 916
7 880
8 014
8 373
9 269
Accumulated Depreciation
1 968
2 164
2 438
2 738
3 130
3 648
4 278
5 086
6 114
7 192
Intangible Assets
5
5
4
46
70
193
209
181
135
105
Note Receivable
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
61
65
360
924
1 595
2 862
4 147
5 535
4 400
2 978
Other Long-Term Assets
11
41
14
16
48
26
48
172
285
504
Total Assets
5 245
N/A
5 992
+14%
7 055
+18%
9 032
+28%
11 095
+23%
15 144
+36%
19 868
+31%
28 289
+42%
32 116
+14%
31 865
-1%
Liabilities
Accounts Payable
99
235
292
385
354
402
526
614
1 142
354
Accrued Liabilities
80
84
89
111
64
69
76
113
124
115
Short-Term Debt
830
580
580
580
580
580
580
0
0
0
Current Portion of Long-Term Debt
255
394
452
533
719
647
704
1 052
877
803
Other Current Liabilities
481
452
490
1 165
853
1 352
1 405
1 687
1 532
1 281
Total Current Liabilities
1 745
1 746
1 903
2 774
2 569
3 050
3 290
3 465
3 676
2 554
Long-Term Debt
566
838
1 040
1 123
1 406
2 360
3 762
3 232
2 368
1 597
Deferred Income Tax
0
0
0
0
0
49
111
153
63
0
Other Liabilities
23
33
41
46
94
104
102
119
134
144
Total Liabilities
2 334
N/A
2 616
+12%
2 984
+14%
3 943
+32%
4 069
+3%
5 562
+37%
7 266
+31%
6 969
-4%
6 239
-10%
4 295
-31%
Equity
Common Stock
784
805
809
809
809
809
809
3 279
3 279
3 279
Retained Earnings
1 438
1 857
2 547
3 568
5 550
8 139
11 063
14 627
18 809
20 305
Additional Paid In Capital
685
706
710
710
710
710
710
3 180
3 180
3 180
Unrealized Security Profit/Loss
4
6
5
3
4
8
0
1
5
13
Treasury Stock
0
0
0
0
1
1
2
2
2
2
Other Equity
0
0
0
0
38
66
22
235
605
796
Total Equity
2 911
N/A
3 375
+16%
4 071
+21%
5 089
+25%
7 026
+38%
9 582
+36%
12 601
+32%
21 320
+69%
25 876
+21%
27 570
+7%
Total Liabilities & Equity
5 245
N/A
5 992
+14%
7 055
+18%
9 032
+28%
11 095
+23%
15 144
+36%
19 868
+31%
28 289
+42%
32 116
+14%
31 865
-1%
Shares Outstanding
Common Shares Outstanding
8
31
31
31
31
31
31
32
32
32

See Also

Discover More